作者
- Cairns, J.A. (3)
- Carlsson, T. (2)
- Emanuelsson, H. (2)
- Falk, L. (2)
- Hall, C. (2)
- Hallstrom, A. (3)
- Held, P. (9)
- Karlson, B.W. (2)
- Peterson, M. (2)
- Weaver, D. (2)
|
總筆數:9
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| N-terminal proANF in acute atrial fibrillation: A biochemical marker ofatrial pressures but not a predictor for conversion to sinus rhythm |
For the Digitalis in Acute Atrial Fibrillation (DAAF) Trial group;Hornestam, B.;Hall, C.;Held, P.;Carlsson, T.;Falk, L.;Karlson, B.W.;Lundstrom, T.;Peterson, M.; |
American Heart Journal |
1998-06-01 |
查看 |
| N-terminal proANF in acute atrial fibrillation: A biochemical marker ofatrial pressures but not a predictor for conversion to sinus rhythm |
For the Digitalis in Acute Atrial Fibrillation (DAAF) Trial group;Hornestam, B.;Hall, C.;Held, P.;Carlsson, T.;Falk, L.;Karlson, B.W.;Lundstrom, T.;Peterson, M.; |
American Heart Journal |
1998-06-01 |
查看 |
| Randomized trial of candesartan cilexetil in the treatment of patients withcongestive heart failure and a history of intolerance toangiotensin-converting enzyme inhibitors |
Granger, C.B.;Ertl, G.;Kuch, J.;Maggioni, A.P.;McMurray, J.;Rouleau, J.-L.;Warner Stevenson, L.;Swedberg, K.;Young, J.;Yusuf, S.;Califf, R.M.;Bart, B.A.;Held, P.;Michelson, E.L.;Sellers, M.A.;Ohlin, G.;Sparapani, R.;Pfeffer, M.A.;Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE);Investigators; |
American Heart Journal |
2000-04-01 |
查看 |
| Should all trials have a Data Safety and Monitoring Committee? |
Cairns, J.A.;Hallstrom, A.;Held, P.; |
American Heart Journal |
2001-01-01 |
查看 |
| Should all trials have a Data Safety and Monitoring Committee? |
Cairns, J.A.;Hallstrom, A.;Held, P.; |
American Heart Journal |
2001-01-01 |
查看 |
| Should all trials have a Data Safety and Monitoring Committee? |
Cairns, J.A.;Hallstrom, A.;Held, P.; |
American Heart Journal |
2001-01-01 |
查看 |
| Effect of ximelagatran on ischemic events and death in patients withatrial fibrillation after acute myocardial infarction in the efficacy andsafety of the oral direct thrombin inhibitor ximelagatran in patients withrecent myocardial damage (ESTEEM) trial |
Tangelder, M.J.D.;Frison, L.;Weaver, D.;Wilcox, R.G.;Bylock, A.;Emanuelsson, H.;Held, P.;Oldgren, J.; |
American Heart Journal |
2008-02-01 |
查看 |
| Effect of ximelagatran on ischemic events and death in patients withatrial fibrillation after acute myocardial infarction in the efficacy andsafety of the oral direct thrombin inhibitor ximelagatran in patients withrecent myocardial damage (ESTEEM) trial |
Tangelder, M.J.D.;Frison, L.;Weaver, D.;Wilcox, R.G.;Bylock, A.;Emanuelsson, H.;Held, P.;Oldgren, J.; |
American Heart Journal |
2008-02-01 |
查看 |
| Design and rationale for the Effects of Ticagrelor and Clopidogrel inPatients with Peripheral Artery Disease (EUCLID) trial |
Berger, J.S.;Katona, B.G.;Jones, W.S.;Patel, M.R.;Norgren, L.;Baumgartner, I.;Blomster, J.;Mahaffey, K.W.;Held, P.;Millegard, M.;Heizer, G.;Reist, C.;Fowkes, F.G.;Hiatt, W.R.; |
American Heart Journal |
2016-05-01 |
查看 |
|
|
|
